`
`Year
`1
`2
`3
`4
`5
`6
`Years 1–3
`Years 1–6
`
`Detrol LA
`
`2,370.0
`
`5,096.0
`
`6,382.0
`
`5,873.0
`
`7,016.0
`
`6,915.0
`
`13,848.0
`
`33,652.0
`
`Oxytrol
`331.0
`
`
`533.0
`
`492.0
`
`441.0
`
`395.0
`
`343.0
`
`1,356.0
`
`2,535.0
`
`Vesicare
`459.0
`
`
`1,297.0
`
`2,065.0
`
`2,635.6
`
`3,071.0
`
`3,300.8
`
`3,821.0
`
`12,828.4
`
`Enablex
`
`385.0
`
`1,104.0
`
`1,539.0
`
`1,624.7
`
`1,646.5
`
`1,705.4
`
`3,028.0
`
`8,004.6
`
`Gelnique
`
`37.0
`
`128.4
`
`142.9
`
`124.4
`
`90.3
`
`55.1
`
`308.3
`
`578.1
`
`Myrbetriq
`17.8
`
`
`487.5
`
`1,084.0
`n/a
`n/a
`n/a
`
`1,589.3
`n/a
`
`Toviaz
`
`111.0
`
`476.8
`
`696.8
`
`799.7
`
`975.1
`
`973.8
`
`1,284.6
`
`4,033.1
`
`Notes and sources:
`Figures are in thousands of prescriptions.
`See Exhibit 1037 and Exhibit 1039.
`
`Petitioner Mylan Pharmaceuticals Inc. - Exhibit 1040 - Page 1